Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-20-014611)

Filing Details

Accession Number:: 0001493152-20-014611
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-08-04 18:47:18
Reporting Period:: 2020-08-03

Accepted Time:: 2020-08-04 18:47:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1642380	Oncocyte Corp	OCX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1383492	S Mitchell Levine	15 Cushing Irvine CA 92618	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, No Par Value	Acquisiton	2020-08-03	10,000	$1.32	36,579	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

2,500.000 shares purchased at $1.3165; 2,500.000 shares purchased at $1.3058; 2,500.000 shares purchased at $1.3169; and 2,500.000 shares purchased at $1.3425.